LY3316531
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
August 07, 2019
A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis
(clinicaltrials.gov)
- P1; N=70; Completed; Sponsor: Eli Lilly and Company; Active, not recruiting ➔ Completed; N=102 ➔ 70
Clinical • Enrollment change • Trial completion
April 04, 2019
A Study of LY3316531 in Healthy Participants
(clinicaltrials.gov)
- P1; N=16; Completed; Sponsor: Eli Lilly and Company; Active, not recruiting ➔ Completed
Clinical • Trial completion
March 08, 2019
A Study of LY3316531 in Healthy Participants
(clinicaltrials.gov)
- P1; N=16; Active, not recruiting; Sponsor: Eli Lilly and Company; N=70 ➔ 16
Clinical • Enrollment change
January 15, 2019
A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis
(clinicaltrials.gov)
- P1; N=102; Active, not recruiting; Sponsor: Eli Lilly and Company; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed
1 to 4
Of
4
Go to page
1